Karen Page
- Immunology top 10%
- Dermatology top 2%
- Urology top 5%
- Oncology
- Molecular Biology
- Co-authors
- Christopher BanfieldElena PeevaMichael S. VincentLori Ann CoxAnindita BanerjeeEmma Guttman‐YasskyBrett KingElizabeth Kieras
- Topics
- Asthma and respiratory diseases (8 papers)Dermatology and Skin Diseases (6 papers)IL-33, ST2, and ILC Pathways (4 papers)
- Cited by
- DermatologyUrologyImmunology
- Partner nations
- United StatesAustraliaHungary
In The Last Decade
Karen Page
24 papers receiving 809 citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Immunology 280
- Dermatology 211
- Urology 144
- Oncology 138
- Molecular Biology 129
Countries citing papers authored by Karen Page
This map shows the geographic impact of Karen Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Page more than expected).
Fields of papers citing papers by Karen Page
This network shows the impact of papers produced by Karen Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Page. The network helps show where Karen Page may publish in the future.
Co-authorship network of co-authors of Karen Page
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Page. A scholar is included among the top collaborators of Karen Page based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Page. Karen Page is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 18 | |
| 5 | 17 | |
| 6 | 5 | |
| 7 | 74 | |
| 8 | A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week resultsbreakdown → | 138 |
| 9 | 42 | |
| 10 | 5 | |
| 11 | 71 | |
| 12 | 1 | |
| 13 | 21 | |
| 14 | 71 | |
| 15 | 123 | |
| 16 | 42 | |
| 17 | 4 | |
| 18 | 2 | |
| 19 | 51 | |
| 20 | 41 |
About Karen Page
Karen Page is a scholar working on Dermatology, Urology and Immunology, having authored 24 papers that have together received 821 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (8 papers), Dermatology and Skin Diseases (6 papers) and IL-33, ST2, and ILC Pathways (4 papers). The work is most often cited by research in Dermatology (211 citations), Urology (144 citations) and Immunology (280 citations). Karen Page has collaborated with scholars based in United States, Australia and Hungary. Frequent co-authors include Christopher Banfield, Elena Peeva, Michael S. Vincent, Lori Ann Cox, Anindita Banerjee, Emma Guttman‐Yassky, Brett King, Elizabeth Kieras, Linda Zhu and Weidong Zhang. Their work appears in journals such as Gastroenterology, Analytical Biochemistry and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.